Institutional Ownership Oramed Pharmaceuticals Inc. (ORMP)
This table provides information about the institutional ownership of Oramed Pharmaceuticals Inc. (ORMP). We have compiled data on the 66 institutions that hold shares in the stock, with a total of 8.11 Million shares, which have been reported (via 13F filing form) to have a value of $20.8 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Jones Financial Companies Lllp
|
Feb 05, 2025 Q4 2024 |
1,072
shares
|
$2,744
0.0% of portfolio
|
Q4 2024
Added 87.41%
|
|
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
Feb 13, 2025 Q4 2024 |
1,000
shares
|
$2,560
0.0% of portfolio
|
Q3 2021
New holding
|
|
|
Mc Ilrath & Eck, LLC
|
Feb 14, 2025 Q4 2024 |
1,000
shares
|
$2,560
0.0% of portfolio
|
Q3 2024
Reduced 50.0%
|
|
|
Bivin & Associates, Inc.
Ponca City, OK |
Aug 11, 2022 Q2 2022 |
800
shares
|
$2,048
0.0% of portfolio
|
Q1 2022
Added 14.29%
|
|
|
Ifp Advisors, Inc
|
Feb 04, 2025 Q4 2024 |
500
shares
|
$1,280
0.0% of portfolio
|
Q1 2024
Reduced 66.67%
|
|
|
Covington Capital Management
|
Nov 14, 2022 Q3 2022 |
325
shares
|
$832
0.0% of portfolio
|
Q3 2021
New holding
|
|
|
Golden State Wealth Management, LLC
Santa Ana, CA |
Jan 28, 2025 Q4 2024 |
303
shares
|
$775
0.0% of portfolio
|
Q4 2024
New holding
|
|
|
Beacon Capital Management, LLC
|
Jan 30, 2025 Q4 2024 |
219
shares
|
$560
0.0% of portfolio
|
Q4 2022
New holding
|
|
|
Hopwood Financial Services, Inc.
Reston, VA |
Feb 07, 2025 Q4 2024 |
200
shares
|
$512
0.0% of portfolio
|
Q4 2024
New holding
|
|
|
Time Scale Financial, Inc.
|
Jul 26, 2023 Q2 2023 |
125
shares
|
$320
0.0% of portfolio
|
Q3 2020
Added 48.81%
|
|
|
Atala Financial Inc
Calabasas, CA |
Feb 10, 2025 Q4 2024 |
100
shares
|
$256
0.0% of portfolio
|
Q4 2024
New holding
|
|
|
Group One Trading, L.P.
Chicago, IL |
Feb 14, 2025 Q4 2024 |
100
shares
|
$256
0.0% of portfolio
|
Q3 2024
Reduced 98.91%
|
|
|
Huntington National Bank
Columbus, OH |
Feb 12, 2025 Q4 2024 |
2
shares
|
$5
0.0% of portfolio
|
Q3 2024
Reduced 99.96%
|